All Assay Guidance Manual content, except where otherwise noted, is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported license (CC BY-NC-SA 3.0), which permits copying, distribution, transmission, and adaptation of the work, provided the original work is properly cited and not used for commercial purposes. Any altered, transformed, or adapted form of the work may only be distributed under the same or similar license to this one.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
The collection of chapters in this eBook is written to provide guidance to investigators who are interested in developing assays useful for the evaluation of collections of molecules to identify probes that modulate the activity of biological targets, pathways, and cellular phenotypes. These probes may be candidates for further optimization and investigation in drug discovery and development.
Originally written as a guide for therapeutic project teams within a major pharmaceutical company, this manual has been adapted to provide guidelines for scientists in academic, non-profit, government and industrial research laboratories to develop potential assay formats compatible with High Throughput Screening (HTS) and Structure Activity Relationship (SAR) measurements of new and known molecular entities. Topics addressed in this manual include:
- Development of optimal assay reagents.
- Optimization of assay protocols with respect to sensitivity, dynamic range, signal intensity and stability.
- Adopting screening assays from bench scale assays to automation and scale up in microtiter plate formats.
- Statistical concepts and tools for validation of assay performance parameters.
- Secondary follow up assay development for chemical probe validation and SAR refinement.
- Data standards to be followed in reporting screening and SAR assay results.
- Glossaries and definitions.
This manual will be continuously updated with contributions from experienced scientists from multiple disciplines working in drug discovery & development worldwide. An open submission and review process will be implemented in the near future on this eBook website, hosted by the National Library of Medicine with content management by the National Center for Advancing Translational Sciences (NCATS, http://ncats.nih.gov/), the newest component of the National Institutes of Health (NIH).
Contents
- Preface
- Introduction
- Basics of Assay Equipment and Instrumentation for High Throughput ScreeningG. Sitta Sittampalam.Published May 1, 2012.
- HPLC-MS/MS for Hit GenerationStefan Jon Thibodeaux, David A Yurek, and James E McGee.Published March 1, 2013.
- Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up CompaniesMichael Hughes, James Inglese, Andrew Kurtz, Ali Andalibi, Lavonne Patton, Chris Austin, Michael Baltezor, Michael Beckloff, Sitta Sittampalam, Michael Weingarten, and Scott Weir.Published May 1, 2012; Last Update: October 1, 2012.
- Basics of Assay Equipment and Instrumentation for High Throughput Screening
- BioAssay Ontology
- Development and Applications of the Bioassay Ontology (BAO) to Describe and Categorize High-Throughput AssaysUma D. Vempati and Stephan C. Schürer.Published May 1, 2012; Last Update: October 1, 2012.
- Development and Applications of the Bioassay Ontology (BAO) to Describe and Categorize High-Throughput Assays
- Cell-Based Assays
- FLIPR™ Assays for GPCR and Ion Channel TargetsMichelle R. Arkin, Patrick R. Connor, Renee Emkey, Kim E. Garbison, Beverly A. Heinz, Todd R. Wiernicki, Paul A. Johnston, Ramani A. Kandasamy, Nancy B. Rankl, and Sitta Sittampalam.Published May 1, 2012; Last Update: October 1, 2012.
- Cell-Based RNAi Assay Development for HTSKok Long Ang, Farhana Feroze, Gopinath Ganji, Yue Li, Jeffrey Weidner, and Sitta Sittampalam.Published May 1, 2012; Last Update: October 1, 2012.
- Assay Development Guidelines for Image-Based High Content Screening, High Content Analysis and High Content ImagingWilliam Buchser, Mark Collins, Tina Garyantes, Rajarshi Guha, Steven Haney, Vance Lemmon, Zhuyin Li, and O. Joseph Trask Jr.Published October 1, 2012.
- Advanced Assay Development Guidelines for Image-Based High Content Screening and AnalysisMark-Anthony Bray, Anne Carpenter, and Imaging Platform, Broad Institute of MIT and Harvard.Published March 1, 2013.
- Nuclear Factor Kappa B (NF-κB) Translocation Assay Development and Validation for High Content ScreeningO. Joseph Trask Jr.Published October 1, 2012.
- Ion Channel ScreeningOwen B McManus, Maria L Garcia, David Weaver, Melanie Bryant, Steven Titus, and James B Herrington.Published October 1, 2012.
- FLIPR™ Assays for GPCR and Ion Channel Targets
- Biochemical Assays
- Basics of Enzymatic Assays for HTSHarold B. Brooks, Sandaruwan Geeganage, Steven D. Kahl, Chahrzad Montrose, Sitta Sittampalam, Michelle C. Smith, and Jeffrey R. Weidner.Published May 1, 2012; Last Update: October 1, 2012.
- Validating Identity, Mass Purity and Enzymatic Purity of Enzyme PreparationsJohn E Scott, Kevin P Williams, Tod Holler, and Andrew Napper.Published May 1, 2012; Last Update: October 1, 2012.
- Mechanism of Action assays for EnzymesJohn Strelow, Walthere Dewe, Phillip W Iversen, Harold B Brooks, Jeffrey A Radding, James McGee, and Jeffrey Weidner.Published May 1, 2012; Last Update: October 1, 2012.
- Assay Development for Protein Kinase EnzymesJ. Fraser Glickman, James McGee, and Andrew Napper.Published May 1, 2012; Last Update: October 1, 2012.
- Inhibition of Protein-Protein Interactions: Non-Cellular Assay FormatsMichelle R. Arkin, Marcie A. Glicksman, Haian Fu, Jonathan J. Havel, and Yuhong Du.Published March 18, 2012; Last Update: October 1, 2012.
- Receptor Binding Assays for HTS and Drug DiscoveryDouglas S Auld, Mark W. Farmen, Steven D. Kahl, Aidas Kriauciunas, Kevin L. McKnight, Chahrzad Montrose, and Jeffrey R. Weidner.Published May 1, 2012; Last Update: October 1, 2012.
- GTPγS Binding AssaysNeil W. DeLapp, Wendy H. Gough, Steven D. Kahl, Amy C. Porter, and Todd R. Wiernicki.Published May 1, 2012; Last Update: October 1, 2012.
- Phospho-ERK AssaysKim E. Garbison, Beverly A. Heinz, Mary E. Lajiness, Jeffrey R. Weidner, and G. Sitta Sittampalam.Published May 1, 2012.
- Impedance-Based TechnologiesKim E. Garbison, Beverly A. Heinz, Mary E. Lajiness, Jeffrey R. Weidner, and G. Sitta Sittampalam.Published May 1, 2012.
- IP-3/IP-1 AssaysKim E. Garbison, Beverly A. Heinz, and Mary E. Lajiness.Published May 1, 2012.
- Immunoassay MethodsKaren L. Cox, Viswanath Devanarayan, Aidas Kriauciunas, Joseph Manetta, Chahrzad Montrose, and Sitta Sittampalam.Published May 1, 2012; Last Update: October 1, 2012.
- Basics of Enzymatic Assays for HTS
- Validation
- HTS Assay ValidationPhilip W. Iversen, Benoit Beck, Yun-Fei Chen, Walthere Dere, Viswanath Devanarayan, Brian J Eastwood, Mark W. Farmen, Stephen J. Iturria, Chahrzad Montrose, Roger A. Moore, Jeffrey R. Weidner, and G. Sitta Sittampalam.Published May 1, 2012; Last Update: October 1, 2012.
- Assay Operations for SAR SupportBenoit Beck, Yun-Fei Chen, Walthere Dere, Viswanath Devanarayan, Brian J. Eastwood, Mark W. Farmen, Stephen J. Iturria, Phillip W. Iversen, Steven D. Kahl, Roger A. Moore, Barry D. Sawyer, and Jeffrey Weidner.Published May 1, 2012; Last Update: October 1, 2012.
- Calculations and Instrumentation used for Radioligand Binding AssaysSteven D. Kahl, G. Sitta Sittampalam, and Jeffrey Weidner.Published May 1, 2012; Last Update: October 1, 2012.
- HTS Assay Validation
- Data and Compound Management
- Data Standardization for Results ManagementRobert M. Campbell, Julia Dymshitz, Brian J. Eastwood, Renee Emkey, David P. Greenen, Julia M. Heerding, Dwayne Johnson, Thomas H. Large, Thomas Littlejohn, Chahrzad Montrose, Suzanne E. Nutter, Barry D. Sawyer, Sandra K. Sigmund, Martin Smith, Jeffrey R. Weidner, and Richard W. Zink.Published May 1, 2012; Last Update: October 1, 2012.
- Data Standardization for Results Management
- In Vivo Assays
- In Vivo Assay GuidelinesJoseph Haas, Jason Manro, Harlan Shannon, Wes Anderson, Joe Brozinick, Arunava Chakravartty, Mark Chambers, Jian Du, Brian Eastwood, Joe Heuer, Stephen Iturria, Philip Iversen, Dwayne Johnson, Kirk Johnson, Michael O’Neill, Hui-Rong Qian, Dana Sindelar, and Kjell Svensson.Published May 1, 2012; Last Update: October 1, 2012.
- In Vivo Assay Guidelines
- Glossary
- Glossary of Quantitative Biology Terms Viswanath Devanarayan, Barry D. Sawyer, Chahrzad Montrose, Dwayne Johnson, David P. Greenen, Sitta Sittampalam, Terry Riss, and Lisa Minor.Published May 1, 2012.
- Glossary of Quantitative Biology Terms
Cover photo courtesy of Manju Swaroop, Research Scientist, NCATS
- Measuring hot flashes: summary of a National Institutes of Health workshop.[Mayo Clin Proc. 2004]Measuring hot flashes: summary of a National Institutes of Health workshop.Miller HGLi RM, . Mayo Clin Proc. 2004 Jun; 79(6):777-81.
- Probe Reports from the NIH Molecular Libraries Program[ 2010]. 2010
- HTS Assay Validation[Assay Guidance Manual. 2004]Iversen PWBeck B, Chen YF, Dere W, Devanarayan V, Eastwood BJ, Farmen MW, Iturria SJ, Montrose C, Moore RA, , et al. Assay Guidance Manual. 2004
- Review Novel trends in high-throughput screening.[Curr Opin Pharmacol. 2009]Mayr LMBojanic D, . Curr Opin Pharmacol. 2009 Oct; 9(5):580-8. Epub 2009 Sep 21.
- Review [Development of antituberculous drugs: current status and future prospects].[Kekkaku. 2006]Review [Development of antituberculous drugs: current status and future prospects].Tomioka HNamba K, . Kekkaku. 2006 Dec; 81(12):753-74.
- Assay Guidance ManualAssay Guidance ManualBookself
Your browsing activity is empty.
Activity recording is turned off.
See more...